Non-coding DNA variants contribute to acute lymphoblastic leukemia (ALL) chemotherapy resistance. St. Jude Children's Research Hospital scientists have identified specific DNA variants in the ...
In a real-world study, only 35% of patients completed the full guideline-recommended 4-6 cycles of chemotherapy as first-line treatment for metastatic bladder cancer. Real-world data show suboptimal ...
Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a specific subset of hormone receptor positive, HER2-negative (HR+/HER2–) ...
An interview with Dr. Beverly Moy from Massachusetts General Hospital, co-chair on “Chemotherapy and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results